Sinclair, Inc. (SBGI) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.57%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.57% | Share-based compensation / revenue. Period ending 2026-06-30. $51.00M ÷ $3.26B × 100 ≈ 1.57% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 3.26B USD | |
| Stock-based compensation | 51.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 215.00M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.26B | $51.00M | $215.00M | (m) | (m) | 1.57% | (m) | (m) |
| 2026-03-31 | (m) | $3.20B | $50.00M | $186.00M | (m) | (m) | 1.56% | (m) | (m) |
| 2025-12-31 | (m) | $3.17B | $51.00M | $173.00M | (m) | (m) | 1.61% | (m) | (m) |
| 2025-09-30 | (m) | $3.34B | $48.00M | $359.00M | (m) | (m) | 1.44% | (m) | (m) |
| 2025-06-30 | (m) | $3.48B | $47.00M | $480.00M | (m) | (m) | 1.35% | (m) | (m) |
| 2025-03-31 | (m) | $3.53B | $46.00M | $523.00M | (m) | (m) | 1.30% | (m) | (m) |
| 2024-12-31 | (m) | $3.55B | $51.00M | $551.00M | (m) | (m) | 1.44% | (m) | (m) |
| 2024-09-30 | (m) | $3.37B | $48.00M | $-101.00M | (m) | (m) | 1.42% | (m) | (m) |
| 2024-06-30 | (m) | $3.22B | $46.00M | $-243.00M | (m) | (m) | 1.43% | (m) | (m) |
| 2024-03-31 | (m) | $3.16B | $49.00M | $-310.00M | $307.00M | (m) | 1.55% | -1.01× | Reported |
| 2023-12-31 | (m) | $3.13B | $45.00M | $-331.00M | $305.00M | (m) | 1.44% | -1.09× | Reported |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $3.93B | $50.00M | $3.98B | $296.00M | (m) | 1.27% | 13.45× | Reported |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $6.13B | $60.00M | $95.00M | $618.00M | (m) | 0.98% | 0.15× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.